With GS Discovery® you can....

Speed up therapeutic candidate selection with higher transient titers delivered in shorter timelines, save money with cost effective reagents, streamline your journey to market by using the same proven CHO cell line and vectors from discovery through to commercial production.

You may also be interested in:
Out-Licensed Expression Technologies
Bispecific Antibody
Monoclonal Antibody
GS Discovery®
GS Gene Expression System®
GSquad® Vectors
GS Xceed® Gene Expression System
View our technical brief

Download now
Latest content
Latest briefing from the Knowledge Center
Monoclonal Antibody Molecule
Article
Lonza Shows Flexibility with Ibex® Design Platform to Accommodate tRNA Synthetase-Derived mAbs
aTyr Pharma is a clinical stage biotech focused on translating findings from a proprietary tRNA...
Andrea Cubitt, Ph.D., Vice President External Scientific Alliances and Intellectual Property, aTyr Pharma
Article
A Small Biotech Recognizes the Importance in How You Think of Manufacturing in Selecting a CDMO
Manufacturing is crucial to the success of any drug development project but is too often overlooked....
micro image
Technical/Service brief
GS Discovery® Transient Expression System
With GS Discovery® you can.... Speed up therapeutic candidate selection with...
Webinar (on-demand)
Solving Bispecific Antibody Heavy-Light Chain Mispairing with bYlok® Technology
Lonza’s bYlok® bispecific pairing technology is an innovative solution that drives correct...
Video
How Does bYlok® Technology Work and How Can It Improve Bispecific Production?
Bispecific antibodies offer numerous potential clinical benefits, and the number of bispecifics in...
Immunogenicity Discovery Services
Interview
Q&A: Why Use GS piggyBac® Transposase Technology for Expression of Your Biotherapeutics?
micro image
Presentation (slides)
Optimizing GMP Manufacturing of Lipid Nanoparticles
Lonza is now offering next-generation encapsulation of nucleic acids with FDmiX. In this...
Article
Simplify the Encapsulation Process of Nucleic Acid Payloads with FDmiX Technology
Enable a reliable, swift scale-up to cGMP manufacturing for mRNA encapsulation with the high-end...
scientists working in lab
Article
Q&A: How to Maximise Cell Line Productivity and Efficiency
In this interview, Dr. Tabitha Bullock, a principal group leader at Lonza, tells us about some...
R&D Blog post
Can Elimination of Preclinical Animal Testing Accelerate the Path to IND?
The US Food and Drug Administration (FDA) can now approve Investigational New Drug (IND)...
R&D Blog post
Moving Away from Animal Testing: What are the Drivers and Which Drug Candidates Might Benefit?
The US Food and Drug Administration (FDA) can now approve Investigational New Drug (IND)...
Fabs & Fc-Fusion whitepaper
White paper
A Comprehensive and Flexible Approach to CMC for Fab and Fc-Fusion Development Programs
New molecular formats are gaining momentum in today’s market. They are extremely diverse and can...